Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 89.54% | -39.62% | 35.45% | -32.21% | -15.60% |
| Total Depreciation and Amortization | -11.91% | -4.60% | 0.37% | 3.19% | 2.64% |
| Total Amortization of Deferred Charges | -- | 1.00% | 2.05% | -- | -- |
| Total Other Non-Cash Items | -69.52% | 267.85% | -182.62% | 7,904.52% | -97.62% |
| Change in Net Operating Assets | 70.02% | -503.51% | 321.63% | -79.20% | 152.58% |
| Cash from Operations | 138.06% | -50.28% | -47.59% | -9.32% | 35.85% |
| Capital Expenditure | -109.89% | 27.75% | -1.81% | 36.15% | 23.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 98.06% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -109.89% | 27.75% | 9.58% | 86.01% | -369.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6,401.27% | 49.36% | -0.84% | -13.75% | 99.41% |
| Issuance of Common Stock | -- | 4,051.35% | 753.85% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 31.38% | 17.15% | -- | 100.00% | 54.67% |
| Cash from Financing | -2,941.08% | 77.99% | -437.74% | 68.69% | 97.93% |
| Foreign Exchange rate Adjustments | 114.29% | 275.00% | 92.79% | -252.05% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.01% | -1.33% | -73.86% | 59.44% | 85.40% |